 |
|
Using Nanoparticles, In Vivo Gene Therapy Activates Brain Stem Cells
July 26, 2005BUFFALO, N.Y. - Using customized nanoparticles that they developed, University at Buffalo scientists have for the first time delivered genes into the brains of living mice with an efficiency that is similar to, or better than, viral vectors and with no observable toxic effect, according to a paper published this week in Proceedings of the National Academy of Sciences.
The paper describes how the UB scientists used gene-nanoparticle complexes to activate adult brain stem/progenitor cells in vivo, demonstrating that it may be possible to "turn on" these otherwise idle cells as effective replacements for those destroyed by neurodegenerative diseases, such as Parkinson's.
In addition to delivering therapeutic genes to repair malfunctioning brain cells, the nanoparticles also provide promising models for studying the genetic mechanisms of brain disease.
"Until now, no non-viral technique has proven to be as effective as the viral vectors in vivo," said co-author Paras N. Prasad, Ph.D., executive director of the UB Institute for Lasers, Photonics and Biophotonics, SUNY Distinguished Professor in UB's Department of Chemistry and principal investigator of the institute's nanomedicine program. "This transition, from in vitro to in vivo, represents a dramatic leap forward in developing experimental, non-viral techniques to study brain biology and new therapies to address some of the most debilitating human diseases."
Viral vectors for gene therapy always carry with them the potential to revert back to wild-type, and some human trials have even resulted in fatalities.
As a result, new research focuses increasingly on non-viral vectors, which don't carry this risk.
Viral vectors can be produced only by specialists under rigidly controlled laboratory conditions. By contrast, the nanoparticles developed by the UB team can be synthesized easily in a matter of days by an experienced chemist.
The UB researchers make their nanoparticles from hybrid, organically modified silica (ORMOSIL), the structure and composition of which allow for the development of an extensive library of tailored nanoparticles to target gene therapies for different tissues and cell types.
A key advantage of the UB team's nanoparticle is its surface functionality, which allows it to be targeted to specific cells, explained Dhruba J. Bharali, Ph.D., a co-author on the paper and post-doctoral associate in the UB Department of Chemistry and UB's Institute for Lasers, Photonics and Biophotonics.
While they are easier and faster to produce, non-viral vectors typically suffer from very low expression and efficacy rates, especially in vivo.
"This is the first time that a non-viral vector has demonstrated efficacy in vivo at levels comparable to a viral vector," Bharali said.
In the UB experiments, targeted dopamine neurons - which degenerate in Parkinson's disease, for example - took up and expressed a fluorescent marker gene, demonstrating the ability of nanoparticle technology to deliver effectively genes to specific types of cells in the brain.
Using a new optical fiber in vivo imaging technique (CellviZio developed by Mauna Kea Technologies of Paris), the UB researchers were able to observe the brain cells expressing genes without having to sacrifice the animal.
Then the UB researchers decided to go one step further, to see if they could not only observe, but also manipulate the behavior of brain cells.
Their finding that the nanoparticles successfully altered the development path of neural stem cells is especially intriguing because of scientific concerns that embryonic stem cells may not be able to function correctly since they have bypassed some of the developmental stages cells normally go through.
"What we did here instead was to reactivate adult stem cells located on the floor of brain ventricles, germinal cells that normally produce progeny that then die if they are not used," said Michal K. Stachowiak, Ph.D., co-author on the paper and associate professor of pathology and anatomical sciences in the UB School of Medicine and Biomedical Sciences. Stachowiak is in charge of in vivo studies at the UB Institute for Lasers, Photonics and Biophotonics.
"It's likely that these stem/progenitor cells will grow into healthy neurons," he said.
"In the future, this technology may make it possible to repair neurological damage caused by disease, trauma or stroke," said Earl J. Bergey, Ph.D., co-author and deputy director of biophotonics at the institute.
The group's next step is to conduct similar studies in larger animals.
The UB research was supported by the John R. Oishei Foundation, the National Science Foundation, the American Parkinson Disease Association and UB's New York State Center of Excellence in Bioinformatics and Life Sciences.
Research at UB's Institute for Lasers, Photonics and Biophotonics has been supported by special New York State funding sponsored by State Sen. Mary Lou Rath.
University at Buffalo
"Until now, no non-viral technique has proven to be as effective as the viral vectors in vivo," said co-author Paras N. Prasad, Ph.D., executive director of the UB Institute for Lasers, Photonics and Biophotonics, SUNY Distinguished Professor in UB's Department of Chemistry and principal investigator of the institute's nanomedicine program. "This transition, from in vitro to in vivo, represents a dramatic leap forward in developing experimental, non-viral techniques to study brain biology and new therapies to address some of the most debilitating human diseases."
Viral vectors for gene therapy always carry with them the potential to revert back to wild-type, and some human trials have even resulted in fatalities.
As a result, new research focuses increasingly on non-viral vectors, which don't carry this risk.
Viral vectors can be produced only by specialists under rigidly controlled laboratory conditions. By contrast, the nanoparticles developed by the UB team can be synthesized easily in a matter of days by an experienced chemist.
The UB researchers make their nanoparticles from hybrid, organically modified silica (ORMOSIL), the structure and composition of which allow for the development of an extensive library of tailored nanoparticles to target gene therapies for different tissues and cell types.
A key advantage of the UB team's nanoparticle is its surface functionality, which allows it to be targeted to specific cells, explained Dhruba J. Bharali, Ph.D., a co-author on the paper and post-doctoral associate in the UB Department of Chemistry and UB's Institute for Lasers, Photonics and Biophotonics.
While they are easier and faster to produce, non-viral vectors typically suffer from very low expression and efficacy rates, especially in vivo.
"This is the first time that a non-viral vector has demonstrated efficacy in vivo at levels comparable to a viral vector," Bharali said.
In the UB experiments, targeted dopamine neurons - which degenerate in Parkinson's disease, for example - took up and expressed a fluorescent marker gene, demonstrating the ability of nanoparticle technology to deliver effectively genes to specific types of cells in the brain.
Using a new optical fiber in vivo imaging technique (CellviZio developed by Mauna Kea Technologies of Paris), the UB researchers were able to observe the brain cells expressing genes without having to sacrifice the animal.
Then the UB researchers decided to go one step further, to see if they could not only observe, but also manipulate the behavior of brain cells.
Their finding that the nanoparticles successfully altered the development path of neural stem cells is especially intriguing because of scientific concerns that embryonic stem cells may not be able to function correctly since they have bypassed some of the developmental stages cells normally go through.
"What we did here instead was to reactivate adult stem cells located on the floor of brain ventricles, germinal cells that normally produce progeny that then die if they are not used," said Michal K. Stachowiak, Ph.D., co-author on the paper and associate professor of pathology and anatomical sciences in the UB School of Medicine and Biomedical Sciences. Stachowiak is in charge of in vivo studies at the UB Institute for Lasers, Photonics and Biophotonics.
"It's likely that these stem/progenitor cells will grow into healthy neurons," he said.
"In the future, this technology may make it possible to repair neurological damage caused by disease, trauma or stroke," said Earl J. Bergey, Ph.D., co-author and deputy director of biophotonics at the institute.
The group's next step is to conduct similar studies in larger animals.
The UB research was supported by the John R. Oishei Foundation, the National Science Foundation, the American Parkinson Disease Association and UB's New York State Center of Excellence in Bioinformatics and Life Sciences.
Research at UB's Institute for Lasers, Photonics and Biophotonics has been supported by special New York State funding sponsored by State Sen. Mary Lou Rath.
University at Buffalo
Nanoparticles News and Current Nanoparticles Events RSSScientists peel away the mystery behind gold's catalytic prowess
Few materials have exercised as much of a hold on the human imagination, or on human history, as has gold.
Nano-sized 'trojan horse' to aid nutrition
Researchers from Monash University have designed a nano-sized "trojan horse" particle to ensure healing antioxidants can be better absorbed by the human body.
University of Pennsylvania Scientists Move Optical Computing Closer to Reality
Scientists at the University of Pennsylvania have theorized a way to increase the speed of pulses of light that bound across chains of tiny metal particles to well past the speed of light by altering the particle shape.
Breaking the 'mucus barrier' with a new drug delivery system
Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society.
Polymer electric storage, flexible and adaptable
The proliferation of solar, wind and even tidal electric generation and the rapid emergence of hybrid electric automobiles demands flexible and reliable methods of high-capacity electrical storage. Now a team of Penn State materials scientists is developing ferroelectric polymer-based capacitors that can deliver power more rapidly and are much lighter than conventional batteries.
Newly detected air pollutant mimics damaging effects of cigarette smoke
A previously unrecognized group of air pollutants could have effects remarkably similar to harmful substances found in tobacco smoke, Louisiana scientists are reporting in a study scheduled for presentation today at the 236th National Meeting of the American Chemical Society.
Turning Waste Material into Ethanol
Say the word "biofuels" and most people think of grain ethanol and biodiesel. But there's another, older technology called gasification that's getting a new look from researchers at the U.S. Department of Energy's Ames Laboratory and Iowa State University. By combining gasification with high-tech nanoscale porous catalysts, they hope to create ethanol from a wide range of biomass, including distiller's grain left over from ethanol production, corn stover from the field, grass, wood pulp, animal waste, and garbage.
UNC study: shape, not just size, impacts effectiveness of emerging nanomedicine therapies
In the budding field of nanotechnology, scientists already know that size does matter. But now, researchers at the University of North Carolina at Chapel Hill have shown that shape matters even more - a finding that could lead to new and more effective methods for treating cancer and other diseases, from diabetes and multiple sclerosis to arthritis and obesity.
Argonne scientists discover networks of metal nanoparticles are culprits in alloy corrosion
Oxide scales are supposed to protect alloys from extensive corrosion, but scientists at U.S. Department of Energy's Argonne National Laboratory have discovered metal nanoparticle chinks in this armor.
Nanoparticles + light = dead tumor cells
Medical physicists at the University of Virginia have created a novel way to kill tumor cells using nanoparticles and light.
More Nanoparticles News Articles
 | Environmental Nanotechnology by Mark Wiesner, Jean-Yves Bottero Explore the Properties of Today's Widely Used Nanomaterials— and Assess Their Potentially Harmful Effects on the Environment Environmental Nanotechnology is the first book to assist you in both understanding the properties of new nanomaterial-centered technology and assessing the potentially harmful effects these materials may have on the environment. Written by a team of 29 leading... |
| Recent Developments in Fiber Electrospinning. : An article from: Nanoparticle News This digital document is an article from Nanoparticle News, published by Thomson Gale on May 1, 2006. The length of the article is 1773 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Recent... | |
 | Nanoparticulate Drug Delivery Systems (Drugs and the Pharmaceutical Sciences) Since the advent of analytical techniques and capabilities to measure particle sizes in nanometer ranges, there has been tremendous interest in the use of nanoparticles for more efficient methods of drug delivery. This expertly written guide addresses the scientific methodologies, formulation, processing, applications, recent trends, and emerging technologies in the research of nanoparticulate... |
 | Magnetoviscous Effects in Ferrofluids (Lecture Notes in Physics Monographs) by Stefan Odenbach Suspensions of magnetic nanoparticles or ferrofluids can be effectively controlled by magnetic fields, which opens up a fascinating field for basic research into fluid dynamics as well as a host of applications in engineering and medicine. The introductory chapter provides the reader with basic information on the structure, and magnetic and viscous properties of ferrofluids. The bulk of this... |
 | Nanostructured Materials: Processing, Properties and Applications, 2nd Edition Nanostructured materials are one of the highest profile classes of materials in science and engineering today, and will continue to be well into the future. Potential applications are widely varied, including washing machine sensors, drug delivery devices to combat avian flu, and more efficient solar panels. Broad and multidisciplinary, the field includes multilayer films, atomic clusters,... |
 | Light Scattering from Polymer Solutions and Nanoparticle Dispersions (Springer Laboratory) by Wolfgang Schärtl Light scattering is a very powerful method to characterize the structure of polymers and nanoparticles in solution. Recent technical developments have strongly enhanced the possible applications of this technique, overcoming previous limitations like sample turbidity or insufficient experimental time scales. However, despite their importance, these new developments have not yet been presented in... |
 | Nanoparticle Technology Handbook Nanoparticle technology, which handles the preparation, processing, application and characterisation of nanoparticles, is a new and revolutionary technology. It becomes the core of nanotechnology as an extension of the conventional Fine Particle / Powder Technology. Nanoparticle technology plays an important role in the implementation of nanotechnology in many engineering and industrial fields... |
 | The Handbook of Nanomedicine by Kewal K. Jain Nanomedicine is clinical medicine with the application of nanobiotechnology, which is currently being used to research the pathomechanism of disease, refine molecular diagnostics, and aid in the discovery, development and delivery of drugs. In The Handbook of Nanomedicine, Prof. Kewal K. Jain distills the voluminous literature relevant to the subject into one concise, comprehensive and... |
 | Colloidal Nanoparticles in Biotechnology (Wiley Series on Surface and Interfacial Chemistry) Learn to use colloidal nanoparticles in a broad range of biotechnological applications Discover new and emerging applications of colloidal nanoparticles. Dr. Abdelhamid Elaissari, internationally respected author and researcher, reports on and analyzes a broad range of important findings from new studies on the use of colloidal nanoparticles in biomedical, food, and environmental... |
| Biomagnetism and Magnetic Biosystems Based on Molecular Recognition Processes (AIP Conference Proceedings) All papers have been peer-reviewed. Point-of-care medical diagnostics could be accelerated by a new generation of lab-on-drip devices exploiting nanoscale magnetic effects. The Conference encompassed biomagnetism, biomolecular sensors based on manipulation/detection of magnetic entities and the associated surface chemistry. It publicized research highlights in nanomagnetism, biology, medicine,... |
| © 2008 BrightSurf.com |